Hawaii Revised Statutes
329. Uniform Controlled Substances Act
329-65 Penalty.

§329-65 Penalty. (a) Any manufacturer, wholesaler, retailer, or other person who does not submit a report as required by section 329-63 or who knowingly submits a report with false or fictitious information shall be fined not more than $5,000, or imprisoned not more than thirty days, or both.
(b) Any manufacturer, wholesaler, retailer, or other person who has previously been convicted of violating subsection (a), upon a subsequent conviction thereof, shall be fined not more than $100,000, or imprisoned not more than one year, or both.
(c) Any manufacturer, wholesaler, retailer, or other person who sells, transfers, or otherwise furnishes any of the substances listed in section 329-61 with knowledge or the intent that the recipient will use the substance to unlawfully manufacture any controlled substance shall be fined not more than $100,000, or imprisoned not more than five years, or both. For the purpose of this part, "unlawfully manufacture" means to manufacture, compound, convert, produce, derive, process, or prepare, either directly or indirectly by chemical extraction, or independently by means of chemical synthesis, any controlled substance specified in section 329-14, 329-16, 329-18, 329-20, or 329-22 without a valid state controlled substance registration as designated under section 329-33.
(d) Any manufacturer, wholesaler, retailer, or other person who possesses any of the substances listed in section 329-61 with the intent to unlawfully manufacture any controlled substance shall be fined not more than $100,000, or imprisoned not more than ten years, or both.
(e) Any person who possesses, sells, distributes, purchases for resale, or causes to be sold, distributed, or purchased for resale any ephedrine-containing product with a label that claims or implies that consumption of the product will produce effects such as ecstasy, euphoria, increased sexual sensations, legal "highs", and other similar effects shall be fined not more than $5,000, or imprisoned not more than one year, or both.
(f) It is unlawful for any person to knowingly or intentionally obtain or attempt to obtain any of the substances listed in section 329-61 or procure or attempt to procure any substances listed in section 329-61:
(1) By fraud, deceit, misrepresentation, embezzlement, or theft;
(2) By furnishing fraudulent documentation or information or the concealment of a material fact regarding the use, location, or ultimate user of the substances listed in section 329-61; or
(3) By the use of a false name, photo identification, general excise tax information, or the giving of a false address.
(g) Any person who violates subsection (f) shall be fined not more than $100,000, or imprisoned not more than five years, or both. [L 1990, c 200, pt of §1; am L 1993, c 225, §3; am L 1999, c 252, §11; am L 2001, c 203, §7; am L 2003, c 151, §10]

Structure Hawaii Revised Statutes

Hawaii Revised Statutes

Title 19. Health

329. Uniform Controlled Substances Act

329-1 Definitions.

329-2 Hawaii advisory commission on drug abuse and controlled substances; number; appointment.

329-3 Annual report.

329-4 Duties of the Hawaii advisory commission on drug abuse and controlled substances.

329-11 Authority to schedule controlled substances.

329-12 Nomenclature.

329-13 Schedule I tests.

329-14 Schedule I.

329-15 Schedule II tests.

329-16 Schedule II.

329-17 Schedule III tests.

329-18 Schedule III.

329-19 Schedule IV tests.

329-20 Schedule IV.

329-21 Schedule V tests.

329-22 Schedule V.

329-23 Republishing and distribution of schedules.

329-31 Rules.

329-31.5 Clinics.

329-32 Registration requirements.

329-33 Registration.

329-34 Revocation and suspension of registration.

329-35 Order to show cause.

329-36 Records of registrants.

329-37 Filing requirements.

329-38 Prescriptions.

329-38.2 Prescriptions; additional restrictions.

329-38.5 Opioid therapy; informed consent process; requirement for written policies.

329-39 Labels.

329-39.5 Opioid warning label.

329-40 Methadone treatment programs.

329-41 Prohibited acts B--penalties.

329-42 Prohibited acts C--penalties.

329-43 Penalties under other laws.

329-43.5 Prohibited acts related to drug paraphernalia.

329-43.6 Overdose prevention; limited immunity.

329-44 Notice of conviction to be sent to licensing board, department of commerce and consumer affairs.

329-45 REPEALED.

329-46 Prohibited acts related to visits to more than one practitioner to obtain controlled substance prescriptions.

329-49 Administrative penalties.

329-50 Injunctive relief.

329-51 Powers of enforcement personnel.

329-52 Administrative inspections.

329-53 Injunctions.

329-54 Cooperative arrangements and confidentiality.

329-55 Forfeitures.

329-56 Burden of proof; liabilities.

329-57 Judicial review.

329-58 Education and research.

329-59 Controlled substance registration revolving fund; established.

329-61 Substances subject to reporting.

329-62 Proper identification.

329-63 Person required to keep records and file reports.

329-64 Exceptions.

329-65 Penalty.

329-66 Theft, loss, and discrepancy reports.

329-67 Permit for conduct of business; applications; forms; fees; renewal; violations.

329-68 Protection of records; divulging confidential information prohibited; penalties.

329-69 Subpoena powers.

329-70 Forfeiture.

329-71 Requirements when selling specific chemicals.

329-72 Rules.

329-73 REPEALED.

329-74 Unlawful transport of pseudoephedrine.

329-75 Sales of products, mixtures, or preparations containing pseudoephedrine; reporting requirement for wholesalers.

329-81 to 91 REPEALED.

329-101 Reporting of dispensation of controlled substances; electronic prescription accountability system; requirements; penalty.

329-102 Central repository.

329-103 Designated state agency.

329-104 Confidentiality of information; disclosure of information.

329-121 Definitions.

329-122 Medical use of cannabis; conditions of use.

329-123 Registration requirements; qualifying patients; primary caregivers.

329-123.5 Registration requirements; qualifying out-of-state patient; caregiver of a qualifying out-of-state patient.

329-124 Insurance not applicable.

329-125 Protections afforded to a qualifying patient, primary caregiver, qualifying out-of-state patient, or caregiver of a qualifying out-of-state patient.

329-125.5 Medical cannabis patient and caregiver protections.

329-125.6 Protections afforded to an owner or qualified employee of a licensed medical cannabis dispensary.

329-126 Protections afforded to a treating physician or advanced practice registered nurse.

329-127 Protection of cannabis and other seized property.

329-128 Fraudulent misrepresentation; penalty.

329-129 Prohibited acts; flammable solvents.

329-130 Authorized sources of medical cannabis.

329-131 Prescription and pharmacy requirements not applicable.